Sign in Pull a receipt

CERO

CERO THERAPEUTICS HOLDINGS, INC.

Healthcare · Biotechnology

$180.63 sample

+3.05 (+1.72%) 1D

Market cap

$707.0B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-21

Alerts

8

Price$180.63 +9.35% 3M daily closessample

190.65164.24

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider buy: General Counsel
Oct 21SEC10-Q filed
Oct 13INSInsider sell: Chief Executive Officer
Oct 07INSInsider sell: General Counsel
Sep 28INSInsider sell: General Counsel
Sep 22INSInsider sell: 10% owner
Sep 15SEC10-Q filed
Sep 08SEC8-K filed: material event

Sign up to see the real CERO record →

Company facts

SEC EDGAR registration

Name: CERO THERAPEUTICS HOLDINGS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -52sample, -100 to +100
Reporting currency: USD

Who is positioning in CERO

sample

Insiders: 6 insider transactions over 90 days, net selling, $843.6M
Congress: 2 members traded over 90 days
Institutions · 13F: 37 funds hold $7.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$41.1B +14.8% y/y

Q4 2024Q3 2026

Inventory$23.0B +12.3% y/y

Q4 2024Q3 2026

Accounts receivable$17.7B +11.9% y/y

Q4 2024Q3 2026

Total debt$48.7B +8.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $620.9B +8.0% 3M
Sample peer B: $153.9B +2.2% 3M
Sample peer C: $507.4B -7.3% 3M
Sample peer D: $166.5B +4.3% 3M
Sample peer E: $546.4B +9.5% 3M